Abstract
42037 Phase 2a Study of Efficacy and Safety of Crisaborole in Patients with Stasis Dermatitis Using a Decentralized Evaluation Method
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jaad.2023.07.830
Publication Date: Sep 1, 2023 |
42037 Phase 2a Study of Efficacy and Safety of Crisaborole in Patients with Stasis Dermatitis Using a Decentralized Evaluation Method
Join us for a 30 min session where you can share your feedback and ask us any queries you have